VIR
Vir Biotechnology Inc
NASDAQ: VIR · HEALTHCARE · BIOTECHNOLOGY
$10.22
+1.34% today
Updated 2026-04-30
Market cap
$1.72B
P/E ratio
—
P/S ratio
25.02x
EPS (TTM)
$-3.16
Dividend yield
—
52W range
$4 – $12
Volume
4.0M
Vir Biotechnology Inc (VIR) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |